Inventor
CECILE SCHIFFER-MANNIOUI
Inventor
FR
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
C12NMicroorganisms or enzymes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
PatentTitleYear
11,987,639Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy202411,690,873Universal chimeric antigen receptor T cells specific for CD22202311,311,575Methods for engineering highly active T cell for immunotherapy202211,304,975Methods for engineering allogeneic and highly active t cell for immunotherapy2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to CELLECTIS (3)· patent assignee history
2022–2024Based in FR· patent location history
2023Patents assigned to CELLECTIS SA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELLECTIS | 3 | 2022–2024 |
| CELLECTIS SA | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| FR | 4 | 2022–2024 |